Alcohol and Substance Use After Bariatric Surgery: Nutritional Risks and Clinical Implications in Long-Term Postoperative Care

Abstract

Metabolic and bariatric surgery (MBS) has evolved into a highly effective neurohormonal intervention for severe obesity; however, it introduces unique long-term vulnerabilities, particularly regarding alcohol (AUD) and substance use disorders (SUD). This review synthesizes the epidemiological, pharmacokinetic, and neurobiological drivers of postoperative substance misuse. Procedures like Roux-en-Y gastric bypass (RYGB) radically alter ethanol metabolism, eliminating first-pass metabolism and accelerating gastric emptying, while simultaneously recalibrating reward pathways, creating a "reward gap" that facilitates addiction transfer. These physiological shifts exacerbate critical micronutrient deficiencies (thiamine, B12, iron), increase the risk of post-bariatric hypoglycemia, and correlate with higher rates of liver cirrhosis and suicide. Furthermore, substance use is a primary driver of suboptimal weight loss trajectories and weight regain. Mitigation requires a lifelong, multidisciplinary framework involving preoperative risk stratification, validated screening (e.g., AUDIT-C), and targeted nutritional supplementation to safeguard the long-term metabolic and psychological benefits of MBS.

Keywords: alcohol-related disorders; bariatric surgery; nutritional deficiencies; postoperative care; risk factors; substance-related disorders.

Figure 1

Pathophysiological mechanism of addiction transfer following (MBS). This flowchart illustrates the transition from pre-operative hyperphagia to post-operative alcohol use. Pre-operatively, food activates mesolimbic dopamine (DA) signaling in the ventral tegmental area (VTA) and nucleus accumbens (NAc) as a coping mechanism. Following MBS, anatomical changes and dumping syndrome physically restrict food intake. Simultaneously, profound hormonal shifts occurs: residual ghrelin signaling may amplify reward sensitivity, while exaggerated surges of GLP-1 and PYY contribute to a caloric “reward deficiency” state. This creates a “Reward Gap” where the recalibrated brain seeks hedonic stimulation, but food is no longer a viable option. Consequently, patients may substitute alcohol, which is rapidly absorbed and rewarding, leading to addiction transfer and a heightened risk of Alcohol Use Disorder (AUD). This process is further modulated by genetic factors (e.g., DRD2), psychiatric history, and stress-axis dysregulation. Although this conceptual model depicts a transition from altered food reward to increased vulnerability to alcohol use, the emergence of postoperative alcohol misuse typically occurs with a delay of 1–2 years rather than immediately after surgery. This temporal pattern likely reflects the progressive nature of neurohormonal adaptation, psychosocial adjustment, and relaxation of early postoperative dietary restrictions. Early postoperative phases are characterized by intensive medical monitoring and dietary limitations, whereas later phases involve stabilization of weight loss, evolving reward signaling, and greater behavioral autonomy, which together may unmask susceptibility to substance use. Accordingly, the proposed “reward gap” should be interpreted as a dynamic and evolving vulnerability rather than an immediate substitution phenomenon [57,60,70,76,78,79,84,88,89,90,91].